Skip to main content
ICU
NASDAQ Life Sciences

SeaStar Medical Posts $4.5M Q3 Net Loss as Operating Expenses Hit $5.2M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.92
Mkt Cap
$10.207M
52W Low
$1.84
52W High
$5.38
52W Position info
4.3% above low
Off High info
64% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ICU is trading near its 52-week low of $1.84 (4.3% above the low).

Summary

SeaStar Medical reported a Q3 net loss of $4.529 million and an operating loss of $4.581 million on $5.168 million of operating expenses, with EPS of -$1.03, on Q3 revenue of $635,000. The loss dwarfs that quarterly revenue, so the business is still burning far more than it brings in. That matters because the last 10-Q showed cash down to $7.0 million with management flagging substantial going-concern doubt — a quarterly burn of this size puts the runway under real pressure. The company has been leaning on capital markets to stay funded, including the October warrant inducement that raised $3.3 million and the S-3 filed October 30 to register the underlying shares. The regulatory side has been the bright spot: FDA Breakthrough Device Designation for the SCD in October and CBER's November 3 determination that the pediatric SAVE registry satisfied post-approval obligations. Watch for the 10-Q filing and any new 424B prospectus supplement under the shelf, which would show fresh dilution.

At the time of this announcement, ICU was trading at $1.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.2M. The 52-week trading range was $1.84 to $5.38. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ICU - Latest Insights

ICU
Nov 03, 2026, 8:21 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $1.79 info
Change: -$0.609 (-25%) info
Market Cap: $10.207M info
ICU
Oct 22, 2026, 12:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $1.79 info
Change: -$1.43 (-44%) info
Market Cap: $10.207M info
ICU
Oct 07, 2026, 8:16 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.26
Real-time Price: $1.79 info
Change: -$1.47 (-45%) info
Market Cap: $10.207M info
ICU
Oct 05, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.54
Real-time Price: $1.79 info
Change: -$1.75 (-49%) info
Market Cap: $10.207M info
ICU
Aug 12, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.20
Real-time Price: $1.79 info
Change: -$1.41 (-44%) info
Market Cap: $10.207M info